[VRDN] QoQ Quarter Result on 30-Jun-2019 [#Q2]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
07-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- 23.50%
YoY- -2.09%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Revenue 828 880 695 2,514 372 476 944 -8.36%
PBT -8,044 -10,118 -11,230 -8,896 -11,629 -10,317 -9,011 -7.28%
Tax 27 50 133 204 339 289 362 -82.25%
NP -8,044 -10,118 -11,230 -8,896 -11,629 -10,317 -9,011 -7.28%
Tax Rate - - - - - - - -
Total Cost 8,872 10,998 11,925 11,410 12,001 10,793 9,955 -7.38%
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
NP Margin -971.50 -1,149.77 -1,615.83 -353.86 -3,126.08 -2,167.44 -954.56 1.17%
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
EPS -2.65 -4.69 -5.42 -4.31 -5.65 -5.02 -4.40 -28.66%
EPS Diluted -2.65 -4.69 -5.42 -4.31 -5.65 -5.02 -4.40 -28.66%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.